Discoloration of nail beds and skin from minocycline
- Oxytetracycline. // Reactions Weekly;4/7/2007, Issue 1146/1147, p22
The article presents the case of a 31-year-old woman who presented with painful fingernails after receiving oxytetracycline for 3 months for rosacea. On examination, the woman had yellow discoloration and onycholysis of all fingernails and toenails. Oxytetracycline was stopped and her nails are...
- Bosentan. // Reactions Weekly;4/21/2012, Issue 1398, p11
The article describes the case of a 46-year-old woman whose transaminase levels increased during treatment with bosentan twice daily for four weeks.
- Anakinra. // Reactions Weekly;8/4/2012, Issue 1413, p9
The article describes the cases of two patients who experienced either injection site reaction or elevated aminotransferase during treatment with anakinra.
- Peramivir. // Reactions Weekly;4/21/2012, Issue 1398, p35
The article describes the case of a 1-year-old infant who experienced elevated aminotransferase levels while being treated with peramivir.
- Mometasone/prednicarbate. // Reactions Weekly;8/3/2013, Issue 1464, p29
The article presents two case studies about the development of rosacea fulminans with ocular involvement after receiving mometasone and prednicarbate.
- Paracetamol. // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p287
The article describes the case of a three-day-old baby who developed increased transaminase levels after being given paracetamol.
- Antineoplastics/prednisone. // Reactions Weekly;1/16/2010, Issue 1284, p10
The article describes two cases of patients with stage IIB Hodgkin's lymphoma who developed nail dystrophy after receiving BEACOPP chemotherapy. The first patient is a 27-year-old man who developed four rings on all of his fingernails, one month after completing the chemotherapy. The second...
- Selenium overdose. // Reactions Weekly;6/28/2008, Issue 1208, p26
The article describes a case of selenium toxicity in a 55-year-old woman following ingestion of selenium-containing liquid supplement. It references a study by M. E. Sutter et al, published in the June 17, 2008 issue of the "Annals of Internal Medicine." The patient reportedly ingested Total...
- Physicians should not overlook drug interactions during rosacea therapy. Nash, Karen // Dermatology Times;Dec98, Vol. 19 Issue 12, p5
Cautions dermatologists not to overlook drug interactions during rosacea therapy. Complications arising from combined medications; Possible metabolic reactions from topical antibiotics; Effect of alcohol-metronidazole type of gel interaction; Other potential adverse reactions.